For most of human history, people could influence genetics mainly through selective breeding. Modern biotechnology allows scientists to work much more directly with DNA.

One of the most important developments is CRISPR, a family of gene-editing technologies that can be programmed to target particular DNA sequences.

A useful simplified way to think about CRISPR is:

Find a DNA sequence → target it → modify it → allow the cell to repair or replace the DNA.

This ability has transformed research in genetics, medicine, agriculture, and biotechnology.

---

What Is Gene Editing?

Gene editing means making a targeted change to DNA.

Depending on the technology and purpose, scientists may try to:

• disable a gene
• correct a DNA variant
• remove a DNA sequence
• insert genetic information
• change how a gene functions
• alter gene regulation

Gene editing differs from traditional selective breeding because scientists can target specific regions of the genome much more directly.

---

What Does CRISPR Mean?

CRISPR stands for:

Clustered Regularly Interspaced Short Palindromic Repeats

The name originally describes particular repeated DNA sequences found in bacteria and archaea.

CRISPR systems evolved as part of microbial defense mechanisms against genetic invaders such as viruses.

Scientists discovered that components of these systems could be adapted into powerful tools for editing DNA.

---

CRISPR Began as a Microbial Defense System

Viruses that infect bacteria are called bacteriophages, or simply phages.

When certain bacteria survive viral infection, they can incorporate small pieces of viral genetic material into CRISPR regions of their genome.

These sequences can later help the bacterium recognize related viral genetic material.

A simplified sequence is:

virus infects bacterium

↓

fragment of viral DNA stored

↓

CRISPR RNA produced

↓

matching viral sequence recognized during later infection

↓

CRISPR-associated protein targets viral genetic material

Scientists adapted this natural molecular targeting system for laboratory gene editing.

---

CRISPR-Cas9

One widely studied CRISPR system uses a protein called Cas9.

Cas9 is an enzyme that can cut DNA.

However, Cas9 needs help identifying where to act.

This is provided by an RNA molecule engineered to direct Cas9 toward a complementary DNA sequence.

This is commonly called a guide RNA, or gRNA.

A simplified CRISPR-Cas9 system therefore contains:

guide RNA = targeting component

Cas9 = DNA-cutting enzyme

---

A Molecular Search System

A useful analogy is to imagine CRISPR-Cas9 as a programmable search tool.

The guide RNA provides information that helps locate the target.

Cas9 performs the molecular action.

So:

guide RNA → "Find this sequence."

Cas9 → "Act at this location."

The analogy is useful, but CRISPR is not literally reading DNA consciously. Recognition depends on molecular interactions between nucleic-acid sequences and proteins.

---

The Guide RNA

The guide RNA contains a sequence designed to complement the target DNA.

Remember the DNA base-pairing rules:

A pairs with T

C pairs with G

RNA uses U instead of T.

Complementary base pairing allows the guide RNA to help direct the CRISPR complex toward a matching DNA sequence.

The ability to change the guide sequence is a major reason CRISPR is so versatile.

---

The PAM Sequence

Cas9 does not simply cut every DNA sequence that matches the guide RNA.

Many Cas proteins also require a nearby short DNA sequence called a PAM.

PAM stands for:

Protospacer Adjacent Motif

For the commonly used Cas9 from Streptococcus pyogenes, a common PAM is:

5′-NGG-3′

where N can be any DNA base.

The PAM helps Cas9 recognize suitable target sites.

Therefore, target selection depends on both:

guide RNA matching

and

an appropriate PAM

---

How CRISPR-Cas9 Editing Works

The process can be simplified into several stages.

Step 1 – Select a Target

Scientists identify a DNA sequence associated with the gene or region they want to modify.

---

Step 2 – Design a Guide RNA

A guide RNA is designed to recognize the target DNA sequence.

---

Step 3 – Deliver the CRISPR Components

The required CRISPR components must reach the target cells.

This is one of the major challenges in gene-editing medicine.

---

Step 4 – Target Recognition

The guide RNA helps the CRISPR complex locate the complementary DNA sequence near an appropriate PAM.

---

Step 5 – DNA Modification

In conventional CRISPR-Cas9 editing, Cas9 creates a break in the DNA.

---

Step 6 – Cellular Repair

The cell recognizes the damaged DNA and attempts to repair it.

This repair process is often what actually produces the genetic change.

---

The Cell Does Much of the Editing

A common misconception is that Cas9 itself rewrites the DNA into exactly the sequence scientists want.

Usually, it does not.

Cas9 can create the targeted DNA break.

The cell's own DNA-repair systems then repair that break.

Scientists can take advantage of these repair mechanisms to produce particular changes.

---

DNA Repair Pathway 1: End Joining

One repair mechanism reconnects broken DNA ends.

This repair can introduce small changes such as:

• deleted bases
• inserted bases

These changes may disrupt the target gene.

Therefore, CRISPR can be used to create a gene knockout.

A knockout prevents or reduces the normal function of a particular gene.

---

Example: Knocking Out a Gene

Suppose a gene contains:

ATG-CCT-GAA-TGC-...

CRISPR targets the gene.

Cas9 creates a break.

During repair, a few bases are lost:

ATG-C---GAA-TGC-...

The altered sequence may no longer be read correctly.

As a result:

gene disrupted → protein altered or not produced → gene function reduced

This allows scientists to investigate what that gene normally does.

---

DNA Repair Pathway 2: Template-Directed Repair

Under suitable conditions, cells can sometimes repair DNA using a supplied DNA template.

Scientists may provide a sequence containing a desired change.

Conceptually:

target DNA cut

↓

repair template available

↓

cell repairs DNA using template

↓

desired sequence may be incorporated

This can potentially allow more precise changes.

However, efficiency varies considerably between cell types and biological situations.

---

Gene Knockout vs Gene Correction

CRISPR can therefore be used in different ways.

Gene Knockout

Goal: disable a gene.

Example:

A gene contributes to an undesirable biological process.

Scientists disrupt the sequence so that the gene no longer functions normally.

Gene Correction

Goal: change a disease-associated DNA sequence toward a desired sequence.

This is generally more technically demanding.

---

Before and After

Imagine a simplified disease-associated sequence:

Before

A – T – G – C – A – G – T

Scientists want:

After

A – T – G – C – G – G – T

Gene editing attempts to change DNA at a specific genomic location rather than replacing the entire genome.

This precision is one reason CRISPR has attracted so much scientific interest.

---

Newer Forms of CRISPR Editing

CRISPR technology has continued to develop.

Not every CRISPR technique works by making a conventional double-stranded DNA break.

Two important developments are:

Base Editing

Can change certain individual DNA bases without necessarily creating a double-stranded break.

Prime Editing

Uses a modified CRISPR system capable of making particular sequence changes through a different mechanism.

These technologies aim to expand the types of genetic changes that can be made and, in some settings, improve precision.

---

CRISPR in Medical Research

CRISPR is extremely useful for studying disease.

Scientists can modify genes in:

• cultured cells
• organoids
• laboratory animals

They can then investigate:

• what a gene does
• how a mutation affects cells
• which genes contribute to disease
• whether a potential treatment works

For example:

suspected disease gene

↓

gene edited

↓

cell behaviour observed

↓

gene function investigated

CRISPR is therefore not only a treatment technology—it is also an important research tool.

---

CRISPR and Genetic Disorders

Some diseases are caused largely by changes in a particular gene.

These can be attractive targets for gene editing because scientists may be able to target the underlying genetic cause.

Potential strategies include:

• correcting a harmful variant
• disabling a harmful gene
• changing gene regulation
• modifying another gene to compensate

---

Ex Vivo Gene Editing

One strategy is ex vivo editing.

Ex vivo means that cells are edited outside the body.

A simplified process is:

cells removed from patient

↓

cells edited in laboratory

↓

edited cells checked

↓

cells returned to patient

This approach can be useful when suitable cells can be removed, manipulated, and returned.

Blood-forming stem cells are an important example.

---

In Vivo Gene Editing

In vivo editing means that gene-editing components are delivered directly into the patient's body.

The challenge becomes getting the editing system to:

• the correct organ
• the correct tissue
• the correct cells

while limiting effects elsewhere.

Delivery is therefore one of the major challenges of gene-editing medicine.

---

Ex Vivo vs In Vivo

---

CRISPR and Sickle Cell Disease

Sickle cell disease is caused by variants affecting hemoglobin.

One gene-editing strategy does not simply repair the original mutation. Instead, edited blood-forming stem cells can be modified so that they produce more fetal hemoglobin, which can reduce sickling.

The overall idea is:

patient blood stem cells collected

↓

target gene regulation edited

↓

edited stem cells returned

↓

new blood cells produce increased fetal hemoglobin

↓

sickling can be reduced

This demonstrates an important principle:

Gene editing does not always have to repair the original mutation directly. Sometimes scientists can alter another part of the biological pathway.

---

CRISPR and Cancer

CRISPR can also be used to study cancer.

Cancer develops through genetic and cellular changes.

Researchers can use CRISPR to investigate:

• genes involved in tumor growth
• drug resistance
• immune responses
• potential treatment targets

Scientists are also studying ways of editing immune cells so they can better recognize or attack cancer cells.

---

CRISPR in Agriculture

Gene editing can also modify plants.

Possible targets include:

• disease resistance
• pest resistance
• drought tolerance
• nutritional characteristics
• storage life
• crop quality
• yield-related traits

Gene editing can sometimes modify an existing plant gene without introducing a gene from a different species.

---

Example: Disease-Resistant Crops

Suppose a plant contains a gene that a pathogen uses to infect its cells.

Scientists might modify that plant gene so the pathogen can no longer exploit it.

Potential result:

infection reduced

↓

fewer plants lost

↓

larger usable harvest

However, scientists must also investigate whether the change affects:

• plant growth
• crop quality
• ecosystems
• other organisms

---

CRISPR and Livestock

Gene editing can potentially be used in animals to investigate or modify traits involving:

• disease resistance
• animal health
• reproduction
• agricultural characteristics

Animal applications raise additional questions involving:

• welfare
• unintended effects
• genetic diversity
• food safety
• regulation

---

CRISPR and Conservation

Gene editing has also been discussed as a possible conservation tool.

Potential applications might include:

• increasing disease resistance
• controlling invasive species
• protecting threatened populations

However, ecological systems are complex.

Changing one population can affect:

• predators
• prey
• competitors
• food webs
• ecosystem processes

Gene editing in wild populations therefore requires particularly careful ecological evaluation.

---

Gene Drives

A gene drive is a genetic system designed to increase the likelihood that a particular genetic variant will be inherited.

Normally, an organism with one copy of a genetic variant might pass it to roughly half its offspring.

A gene drive can bias inheritance so the genetic change spreads through a population more rapidly.

Potential applications have been investigated for organisms such as mosquitoes.

But gene drives create major ecological and ethical concerns because a genetic change could potentially spread beyond the organisms initially released.

---

Potential Benefits of Gene Editing

Gene editing could potentially provide important benefits.

Medicine

• treat genetic disorders
• study disease
• engineer therapeutic cells
• identify drug targets

Agriculture

• improve disease resistance
• reduce crop losses
• improve nutritional traits
• increase environmental tolerance

Research

• investigate gene function
• create disease models
• study development

Biotechnology

• engineer microorganisms
• improve production systems
• manufacture useful biological products

---

Scientific Risk: Off-Target Editing

One important concern is off-target editing.

The guide RNA is designed to recognize a particular sequence.

However, other regions of the genome may sometimes be sufficiently similar that unintended editing can occur.

Conceptually:

intended target → desired edit

but potentially:

similar unintended site → unwanted edit

Modern design and analysis methods can reduce this risk, but off-target effects remain an important consideration.

---

On-Target Unintended Effects

Not all unwanted changes occur at the wrong location.

Sometimes CRISPR acts at the correct target, but repair produces an unexpected result.

Possible outcomes can include:

• unexpected insertions
• deletions
• rearrangements

Therefore:

correct location does not automatically mean correct outcome.

Scientists must evaluate both off-target and on-target unintended changes.

---

Mosaicism

When editing embryos or developing organisms, not every cell may receive exactly the same edit.

This can create mosaicism.

For example:

Cell A → desired edit

Cell B → different edit

Cell C → no edit

The resulting organism contains genetically different groups of cells.

This can make outcomes difficult to predict.

---

Delivery Problems

A CRISPR system is useful only if it reaches the correct cells.

Imagine treating a genetic disease affecting the heart.

Editing molecules circulating elsewhere in the body are not enough.

They must reach:

the correct tissue → the correct cells → in sufficient amounts

without causing unacceptable effects elsewhere.

Possible delivery approaches under research include:

• viral vectors
• lipid nanoparticles
• other molecular delivery systems
• direct treatment of cells outside the body

Delivery remains a major area of gene-editing research.

---

Immune Responses

CRISPR systems contain biological molecules that may sometimes interact with the immune system.

For therapeutic use, researchers must consider whether:

• proteins trigger immune responses
• delivery systems cause inflammation
• previously existing immunity affects treatment

This is another reason laboratory success does not automatically translate into a safe medical treatment.

---

Gene Editing Is Not Always Permanent in Every Cell

Whether an edit persists depends on:

• which cells were edited
• whether those cells divide
• whether edited cells survive
• whether stem cells were targeted

For example, editing a short-lived cell population may have a temporary effect if new unedited cells replace them.

Editing long-lived stem cells could potentially have much longer-lasting effects.

---

Somatic Gene Editing

Somatic gene editing modifies ordinary body cells.

Examples include:

• blood stem cells
• liver cells
• immune cells

Changes made to somatic cells generally are not inherited by future children.

The consequences primarily affect the treated person.

---

Germline Gene Editing

Germline editing involves genetic changes that could become heritable.

This could involve:

• eggs
• sperm
• embryos that develop into individuals

A heritable edit could potentially be passed:

individual

↓

children

↓

grandchildren

↓

future generations

This makes germline editing ethically different from most somatic treatments.

---

Ethical Issue: Future Generations

Future generations cannot consent to genetic modifications made before they exist.

This creates questions involving:

• autonomy
• safety
• responsibility
• uncertainty

A harmful somatic edit may affect one patient.

A harmful heritable edit could potentially affect descendants.

The possibility of inheritance therefore changes the scale of the ethical problem.

---

Treatment vs Enhancement

Another ethical question concerns the purpose of gene editing.

Consider:

Treatment

Editing cells to address a severe genetic disease.

Prevention

Editing genetic material to reduce future disease risk.

Enhancement

Editing genes with the goal of changing characteristics beyond treating or preventing disease.

Possible hypothetical enhancement targets might involve:

• physical traits
• athletic characteristics
• appearance

The distinction is not always simple.

For example:

At what point does disease prevention become enhancement?

Different societies may answer this differently.

---

"Designer Babies"

The phrase designer babies is commonly used in public discussions of embryo editing.

However, it can be misleading.

Complex characteristics such as:

• intelligence
• personality
• athletic ability
• behaviour

usually involve many genes as well as environmental influences.

There is rarely a single:

"intelligence gene"

or

"athletic gene."

Therefore, the idea that CRISPR could simply select or program complex human characteristics greatly oversimplifies genetics.

---

Equity and Access

Suppose a gene-editing treatment successfully cures a serious disease.

But it costs hundreds of thousands of dollars.

Important questions include:

• Who receives treatment?
• Who pays?
• Will access depend on wealth?
• Will treatments be available globally?
• Could genetic technologies increase existing inequalities?

This connects gene editing with the bioethical principle of justice.

---

Consent

Somatic gene therapy can often involve consent from the patient or an authorized decision-maker.

Heritable editing creates a different problem.

Future descendants cannot consent to changes that may affect their genomes.

Researchers must therefore consider not only:

Can we make the edit?

but also:

Who has the authority to make that decision?

---

Environmental Ethics

Gene editing in wild organisms can potentially affect entire ecosystems.

Imagine releasing gene-edited mosquitoes.

Possible benefits might include reducing transmission of a serious disease.

Possible concerns might include:

• ecological disruption
• spread across political borders
• unintended genetic changes
• evolution of resistance
• difficulty reversing the intervention

This creates questions about who should participate in decisions affecting shared ecosystems.

---

Regulation

Gene-editing technologies are regulated differently around the world and according to their application.

Regulation may consider:

• medical safety
• environmental effects
• food safety
• animal welfare
• clinical evidence
• heritability
• informed consent

Regulation may also change as scientific evidence and technologies develop.

---

Evaluating a Gene-Editing Technology

A useful framework is:

1. What is being edited?

Which organism, tissue, cell, or gene?

2. Why?

What problem is the edit intended to solve?

3. What is the evidence?

How effective is the edit?

4. What are the risks?

Consider:

• off-target changes
• unintended on-target effects
• delivery problems
• immune responses
• mosaicism

5. Is the change inherited?

Somatic and heritable editing create different ethical questions.

6. What alternatives exist?

Could another treatment or technology solve the problem?

7. Who benefits?

Consider patients, farmers, companies, communities, or ecosystems.

8. Who carries the risk?

Benefits and risks may not fall on the same people.

---

Worked Example 1: Guide RNA

A scientist wants Cas9 to target a particular gene.

Why is the guide RNA important?

Answer

The guide RNA contains a sequence that helps direct the CRISPR complex toward a complementary DNA target.

Changing the guide RNA sequence allows scientists to target different genomic locations.

---

Worked Example 2: Gene Knockout

Scientists use CRISPR to cut a gene.

DNA repair introduces a small deletion that changes the reading frame.

What might happen?

Answer

The altered gene may no longer produce a functional protein.

This creates a gene knockout.

Researchers can then observe the effect to learn about the gene's normal function.

---

Worked Example 3: Ex Vivo Treatment

A patient has a genetic blood disorder.

Doctors:

1. remove blood-forming stem cells,
2. edit them using CRISPR,
3. test the cells,
4. return them to the patient.

Is this ex vivo or in vivo editing?

Answer

Ex vivo.

The editing occurs outside the patient's body.

---

Worked Example 4: Off-Target Effects

A guide RNA is designed for Gene A.

Testing shows:

98% of desired cells contain the intended edit

but

a small percentage also contain changes at another genomic site.

Why is this important?

Answer

The additional change is a possible off-target effect.

Scientists would need to determine:

• which DNA sequence changed
• how frequently it occurred
• whether important genes were affected
• whether the change creates a meaningful health risk

A high rate of intended editing does not automatically establish safety.

---

Worked Example 5: Agriculture

A gene-edited crop is resistant to a fungal disease.

Field trials show:

• 30% greater harvested yield during severe outbreaks
• no yield advantage when the disease is absent
• reduced fungicide use
• no major environmental effects detected during three years of trials

Evaluate the claim:

"Gene editing increases the crop's yield by 30%."

Answer

The statement is too broad.

The evidence shows that the crop produced 30% more harvested yield under severe disease pressure.

The difference may result primarily from reducing crop losses rather than increasing the plant's maximum productive capacity.

Longer-term environmental evidence may also be useful.

---

Worked Example 6: Heritable Editing

Scientists can potentially correct an inherited disease-associated variant in an embryo.

However:

• another reproductive option is available
• off-target risk is low but not zero
• long-term effects cannot be completely predicted
• the genetic change could be inherited

What ethical principles are relevant?

Answer

Beneficence: Could the edit prevent serious disease?

Non-maleficence: Could unintended changes cause harm?

Autonomy: Future individuals cannot consent.

Justice: Who would have access to the technology?

The availability of alternatives is also important when evaluating whether the additional risks are justified.

---

Common Mistakes

Mistake 1: "CRISPR is a gene."

CRISPR refers to biological systems and technologies used for targeted genetic manipulation. Cas proteins are enzymes involved in many CRISPR systems.

---

Mistake 2: "Cas9 knows which gene scientists want."

Cas9 has no awareness.

Molecular interactions involving the guide RNA and target DNA provide sequence specificity.

---

Mistake 3: "CRISPR simply replaces bad genes with good genes."

CRISPR can produce many types of edits. Some treatments disrupt genes or alter regulation rather than replacing an entire gene.

---

Mistake 4: "Cas9 does all the editing."

Cas9 can create a targeted DNA break, but cellular DNA-repair mechanisms often generate the resulting genetic change.

---

Mistake 5: "CRISPR always makes exactly the intended change."

Editing can produce off-target changes or unintended outcomes at the intended target.

---

Mistake 6: "Gene editing and genetic modification are completely different."

Gene editing is a form of genetic modification. However, gene editing may modify an organism's existing DNA without introducing DNA from another species.

---

Mistake 7: "CRISPR can easily change complex traits such as intelligence."

Complex traits usually involve many genes and environmental influences.

---

Mistake 8: "Somatic gene editing will be inherited."

Somatic edits generally affect body cells and are not passed to offspring.

---

Mistake 9: "All gene editing is inherited."

Only edits involving reproductive cells or developmental stages that contribute to the germline could become heritable.

---

Mistake 10: "If CRISPR works in cells in a laboratory, it will automatically work as a medicine."

A medical treatment must also solve problems involving delivery, safety, effectiveness, immune responses, manufacturing, and long-term outcomes.

---

Check Your Understanding

1. CRISPR

What does CRISPR stand for?

Describe its original biological role in bacteria and archaea.

2. CRISPR-Cas9

Explain the roles of:

• guide RNA
• Cas9
• target DNA
• PAM sequence

3. Gene Editing

Put these events into a logical sequence:

• cellular DNA repair occurs
• guide RNA recognizes target DNA
• genetic sequence is changed
• Cas9 acts at the target

Then explain each stage.

4. DNA Repair

Explain how DNA repair can result in:

a gene knockout

and

a more precise sequence change.

5. Ex Vivo vs In Vivo

Compare ex vivo and in vivo gene editing.

Give one advantage and one challenge of each.

6. Applications

Describe one possible application of CRISPR in each area:

• medicine
• agriculture
• scientific research
• biotechnology

7. Scientific Risks

Explain the difference between:

off-target editing

and

unintended on-target editing.

Why must both be investigated?

8. Somatic vs Germline

Compare somatic and germline gene editing.

Why does heritable editing raise additional ethical concerns?

9. Treatment vs Enhancement

Explain the difference between using gene editing for:

treatment

and

enhancement.

Why might the boundary between them sometimes be difficult to define?

10. CRISPR Challenge

Scientists develop a CRISPR treatment for a serious inherited disorder.

Clinical evidence shows:

• 85% of treated patients experience major improvement
• 8% experience significant treatment-related complications
• editing occurs in somatic stem cells
• the changes are not inherited
• rare unintended DNA changes have been detected
• the treatment costs approximately $600,000
• an existing medicine reduces symptoms but requires lifelong treatment
• long-term effects beyond 15 years remain uncertain

Evaluate the gene-editing treatment.

Organize your answer under:

Scientific evidence

Potential benefits

Potential risks

Somatic vs heritable effects

Alternative treatments

Autonomy and informed consent

Justice and access

Long-term uncertainty

Your justified conclusion

---

Key Terms

• Gene editing – targeted modification of DNA
• CRISPR – family of biological systems adapted for targeted genetic manipulation
• Cas protein – CRISPR-associated protein
• Cas9 – DNA-targeting enzyme widely used in CRISPR gene editing
• Guide RNA (gRNA) – RNA molecule that helps direct a CRISPR system toward a target sequence
• Target sequence – DNA region selected for editing
• PAM – short DNA motif required by many Cas proteins for target recognition
• DNA repair – cellular mechanisms that repair damaged DNA
• Gene knockout – disruption of a gene so its normal function is lost or reduced
• Base editing – gene-editing approach capable of changing certain individual DNA bases without a conventional double-strand break
• Prime editing – CRISPR-derived approach capable of making particular targeted DNA changes
• Ex vivo editing – editing cells outside the body before returning them
• In vivo editing – editing cells directly within the body
• Off-target effect – unintended genetic change at another genomic location
• On-target effect – genetic change at the intended target location
• Mosaicism – presence of genetically different groups of cells within one organism
• Somatic editing – genetic modification of non-reproductive body cells
• Germline editing – genetic modification that can potentially become heritable
• Gene drive – genetic system designed to increase inheritance of a particular genetic variant
• Genetic enhancement – genetic modification intended to alter characteristics beyond treating or preventing disease
• Genome – complete genetic material of an organism

---

Key Takeaways

• CRISPR originated from microbial systems that help defend against genetic invaders such as viruses.
• CRISPR technologies allow scientists to target particular DNA sequences for modification.
• In CRISPR-Cas9 editing, the guide RNA helps determine the target, while Cas9 acts on the DNA.
• Target recognition by many Cas proteins also requires a nearby PAM sequence.
• Conventional Cas9 editing can create a DNA break, after which the cell's own DNA-repair mechanisms produce the resulting change.
• CRISPR can be used to disable genes, modify sequences, alter gene regulation, and investigate gene function.
• Newer approaches such as base editing and prime editing expand the types of changes scientists can attempt.
• Gene editing has applications in medicine, agriculture, research, biotechnology, and potentially conservation.
• Medical editing may occur ex vivo, where cells are modified outside the body, or in vivo, where editing occurs inside the patient.
• Gene editing can sometimes treat disease without directly repairing the original mutation—for example, by changing another gene in the same biological pathway.
• Important scientific risks include off-target editing, unintended on-target changes, mosaicism, delivery problems, and immune responses.
• Somatic editing generally affects only the treated individual, while germline editing can potentially affect future generations.
• Heritable genome editing therefore raises additional questions involving safety, consent, responsibility, and long-term consequences.
• Complex characteristics usually involve many genes plus environmental influences, so CRISPR cannot simply program traits such as intelligence or personality.
• Ethical evaluation should consider benefits, harms, autonomy, justice, alternatives, uncertainty, and who carries the risks.
• Gene editing is a powerful technology, but its usefulness depends not only on whether scientists can make a DNA change, but also on whether they can make the intended change safely, reliably, and responsibly.